GDF15 and systemic sclerosis: Among them, only GDF-15 (p < 0.001) and MR-proANP (p < 0.05) levels were found to be statistically higher in patients with systemic sclerosis compared to controls; more data emerged from a detailed analysis of heart biomarkers.